Upadacitinib and ustekinumab combination treatment for a refractory case of spondyloarthritis and Crohn's disease

Clin Exp Rheumatol. 2023 Oct 5. doi: 10.55563/clinexprheumatol/qsy3kc. Online ahead of print.NO ABSTRACTPMID:37812461 | DOI:10.55563/clinexprheumatol/qsy3kc

Source: Clinical and Experimental Rheumatology - October 9, 2023 Category: Rheumatology Authors: Elena Bianchi Anna Paola Pata Luca Cantarini Bruno Frediani Stefano Gentileschi Source Type: research